E. James Constantine is Director at NUMEREX CORP /PA/ (NMRX). They have made 5 open-market trades across 1 company since 2010, most recently 2015-07-29.
CIK 0001448493
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $200K since 2010, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NMRX | 74,656 | $286K |
Shares reported on the most recent Form 4, priced at the 2015-07-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NMRX | SELL | 2015-05-18 | 2015-05-20 | $8.88 | $133K | -10.8% | -5.5% | -5.5% |
| NMRX | SELL | 2015-05-14 | 2015-05-18 | $9.17 | $46K | -10.8% | -5.5% | -5.5% |
| NMRX | BUY | 2013-08-13 | 2013-08-14 | $10.50 | $100K | -10.8% | -5.5% | -5.5% |
| NMRX | BUY | 2010-06-07 | 2010-06-15 | $4.48 | $9K | -10.8% | -5.5% | -5.5% |
| NMRX | BUY | 2010-05-28 | 2010-06-14 | $4.73 | $91K | -10.8% | -5.5% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.